BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2264338)

  • 21. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases].
    Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H
    Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA.
    Hertel A; Baum RP; Lorenz M; Baew-Christow T; Encke A; Hör G
    Br J Cancer Suppl; 1990 Jul; 10():34-6. PubMed ID: 2166552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
    Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
    J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunoscintigraphy of colorectal carcinomas with 99mTc-labelled antibodies.
    Artiko V; Petrović M; Sobić-Saranović D; Antić A; Koljević-Marković A; Krajnović-Jaksić E; Saranović D; Petrović N; Stojković M; Durutović D; Zuvela M; Radovanović-Bobić A; Galun D; Petrasinović Z; Pavlović S; Krivokapić Z; Obradović V
    Hepatogastroenterology; 2011; 58(106):347-51. PubMed ID: 21661394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and role of repeated administrations of Indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE 025 in the postoperative follow-up of colorectal carcinoma patients.
    Abdel-Nabi HH; Doerr RJ; Chan HW; Farrell E; Evans NH; Spaulding MB; Schweighardt S; Merchant EB
    J Nucl Med; 1992 Jan; 33(1):14-22. PubMed ID: 1730980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 99mTc-labeled monoclonal anti-carcinoembryonic antigen antibody (BW 431/26). Clinical results in the detection of colorectal carcinomas and recurrences.
    Lind P; Langsteger W; Költringer P; Lechner P; Beham A; Arian Schad K; Eber O
    Scand J Gastroenterol; 1989 Dec; 24(10):1205-11. PubMed ID: 2602902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
    Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD
    Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer].
    Campos Villarino LM; Pajares Vinardell M; Freire Macias JM; Vale Gonsalves EI; Millán Núñez-Cortés J; Senra Varela A
    An Med Interna; 1991 Aug; 8(8):377-81. PubMed ID: 1768746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The clinical relevance of anti-CEA immunoscintigraphy with the 99mTc-labelled monoclonal antibody BW 431/26. A critical assessment after 119 studies].
    Hach A; Wittig B; Piepenburg R; Steinert H; Lahmann C; Dippold W; Hahn K
    Rofo; 1992 Jul; 157(1):3-10. PubMed ID: 1638001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunoscintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer.
    Lind P; Smola MG; Lechner P; Ratschek M; Klima G; Költringer P; Steindorfer P; Eber O
    Int J Cancer; 1991 Apr; 47(6):865-9. PubMed ID: 2010229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
    Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
    J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody.
    Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R
    Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection efficiency of colorectal carcinoma recurrence using technetium pertechnetate-anti-carcinoembryonic antigen monoclonal antibody BW 431/26.
    Zwas ST; Goshen E; Rath P; Brenner H; Klein E; Ben-Ari G
    Cancer; 1995 Jul; 76(2):215-22. PubMed ID: 8625094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125.
    Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G
    Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A fundamental study of immunoscintigraphy with 131I-labeled anti-CA 19-9 and anti-CEA monoclonal antibodies--imaging of tumor-bearing mice by IMACIS-1 and cell ELISA with human tumor cells].
    Nogami T; Miura H; Ohmi S; Kazahaya Y
    Kaku Igaku; 1990 May; 27(5):427-36. PubMed ID: 2395226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab')2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicenter study.
    Siccardi AG; Buraggi GL; Callegaro L; Colella AC; De Filippi PG; Galli G; Mariani G; Masi R; Palumbo R; Riva P
    Cancer Res; 1989 Jun; 49(11):3095-103. PubMed ID: 2655889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of specific antibody pretreatment on liver uptake of 111In-labeled anticarcinoembryonic antigen monoclonal antibody in nude mice bearing human colon cancer xenografts.
    Beatty BG; Beatty JD; Williams LE; Paxton RJ; Shively JE; O'Connor-Tressel M
    Cancer Res; 1989 Mar; 49(6):1587-94. PubMed ID: 2924309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical results of immunoscintigraphy in a variety of malignant tumors with special reference to immunohistochemistry.
    Biersack HJ; Bockisch A; Oehr P; Knoblich A; Hartlapp J; Biltz H; Jaeger N; Bellmann O; Vogel J; Björklund B
    Nuklearmedizin; 1986 Oct; 25(5):167-71. PubMed ID: 3540857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations.
    Macmillan CH; Perkins AC; Wastie ML; Leach IH; Morgan DA
    Br J Cancer; 1993 Jun; 67(6):1391-4. PubMed ID: 8390288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of complete versus fragmented technetium-99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer.
    Behr TM; Becker WS; Bair HJ; Klein MW; Stühler CM; Cidlinsky KP; Wittekind CW; Scheele JR; Wolf FG
    J Nucl Med; 1995 Mar; 36(3):430-41. PubMed ID: 7884505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.